Telenor ASA 'A-/A-2' Ratings Affirmed Reflecting Continued Strength; Outlook Stable Mar 03

  • ID: 1831957
  • March 2003
  • Standard & Poors
1 of 3

LONDON (Standard & Poor's) March 13, 2003--Standard & Poor's Ratings Services said today it affirmed its 'A-' long-term corporate credit and senior unsecured debt ratings, and its 'A-2' short-term corporate credit and commercial paper ratings, on Telenor ASA, following a review of the Norway-based telecommunications operator. The outlook is stable. "The ratings reflect the continued strength of the domestic fixed-line and mobile operations, which generated about 67% of group EBITDA for the quarter ended Dec. 31, 2002, combined with improved domestic cash flow primarily due to reduced capital expenditure", said Standard & Poor's credit analyst Simon Redmond. These positive factors are set against the company's higher business and financial risk as a result of increased holdings in mobile operators in...

Companies mentioned in this report are: Telenor ASA
Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Telenor ASA

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.